Ikena Oncology

$13.35 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Ikena Oncology

Ikena Oncology, Inc. operates as a biotechnology company. The Company focuses on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. Ikena Oncology serves customers in the United States.

Stock Analysis

last close $13.35
1-mo return 12.5%
3-mo return 3.8%
avg daily vol. 120.12T
52-week high 37.61
52-week low 9.63
market cap. $548M
forward pe -
annual div. -
roe -100.9%
ltg forecast -
dividend yield -
annual rev. $11M
inst own. 76.7%
baraka

Subscribe now for daily local and international financial news

Subscribe